Celecoxib and Cardiovascular Risk

被引：0
|
作者：
Kayyali, Andrea
机构：
来源：
AMERICAN JOURNAL OF NURSING | 2009年 / 109卷 / 03期
关键词：
D O I：
10.1097/01.NAJ.0000346923.59875.c9
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [41] Celecoxib: no increased risk of CV events
    Reactions Weekly, 2002, 892 (1) : 4 - 4
  • [42] Celecoxib/rofecoxib: increased risk of thrombosis?
    Reactions Weekly, 2001, 876 (1) : 5 - 5
  • [43] Celecoxib reduces risk of ulcer bleeding
    Sarah Onuora
    Nature Reviews Rheumatology, 2017, 13 (6) : 324 - 324
  • [44] Cardiovascular Safety of Celecoxib Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen (PRECISION)
    Schroer, K.
    Nitschmann, S.
    INTERNIST, 2017, 58 (08): : 863 - 865
  • [45] Effect of Evening Primrose Oil and Omega-3 Polyunsaturated Fatty Acids on the Cardiovascular Risk of Celecoxib in Rats
    Zaitone, Sawsan A.
    Moustafa, Yasser M.
    Mosaad, Sarah M.
    El-Orabi, Naglaa F.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2011, 58 (01) : 72 - 79
  • [46] CLINICAL PREDICTORS OF CARDIOVASCULAR OUTCOMES IN PATIENTS ON CELECOXIB, IBUPROFEN, AND NAPROXEN
    Riaz, Haris
    Reed, Grant
    Wang, Qiuqing
    Wisniewski, Lisa
    Wolski, Kathy
    Lincoff, A.
    Nissen, Steven
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1779 - 1779
  • [47] Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study
    Gudbjornsson, Bjorn
    Thorsteinsson, Sigurdur B.
    Sigvaldason, Helgi
    Einarsdottir, Rannveig
    Johannsson, Magnus
    Zoega, Helga
    Halldorsson, Matthias
    Thorgeirsson, Gudmundur
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (06) : 619 - 625
  • [48] Celecoxib CV risk increased at higher dosages
    Reactions Weekly, 2008, 1197 (1) : 3 - 3
  • [49] Cardiovascular risk associated with celecoxib or etoricoxib: a meta-analysis of randomized controlled trials which adopted comparison with placebo or naproxen
    De Vecchis, R.
    Baldi, C.
    Di Biase, G.
    Ariano, C.
    Cioppa, C.
    Giasi, A.
    Valente, L.
    Cantatrione, S.
    MINERVA CARDIOANGIOLOGICA, 2014, 62 (06): : 437 - 448
  • [50] GASTROINTESTINAL EVENTS IN ARTHRITIS PATIENTS AT INCREASED CARDIOVASCULAR RISK TREATED CHRONICALLY WITH CELECOXIB, NAPROXEN OR IBUPROFEN: THE PRECISION RANDOMIZED CONTROLLED TRIAL
    Yeomans, Neville D.
    Graham, David Y.
    Husni, M. E.
    Solomon, Daniel H.
    Stevens, Tyler
    Vargo, John J.
    Wang, Qiuqing
    Wisniewski, Lisa M.
    Wolski, Katherine E.
    Nissen, Steven E.
    GASTROENTEROLOGY, 2017, 152 (05) : S166 - S166
12345